The National Comprehensive Cancer Network (NCCN)-a global not-for-profit alliance of leading cancer centers-is taking part in a two-day meeting at the Middle East North Africa (MENA)-NCCN Regional Coordinating Center, beginning today.
Quince buys a rare disease biotech; Heron reduces headcount
Quince Therapeutics will buy the private biotech EryDel SpA in a stock deal, with up to $485 million on the line in development, regulatory and